Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Boyd Steven
Relationship:   10% Owner
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   18    
Direct Shares   47,075,098    

Indirect Shares

   40,287,245      
Direct Value   $128,455,406    

Indirect Value

   $40,265,984      
Total Shares   87,362,343      
Total Value   $168,721,391      


Avalo Therapeutics, Inc $14,783 Dynatronics Corp $233,800 Kiora Pharmaceuticals $625,814 Fresh Tracks Therapeutics Ord Shs $1,466,920 Alimera Sciences Inc $2,115,480 Cassava Sciences Inc $36,379,020 Bio-Path Holdings, Inc. $46,806 AYTU BIOSCIENCE, INC $4,228,491 Achieve Life Sciences Inc $4,404,511 AMAG Pharmaceuticals Inc $56,650,000 Onconova Therapeutics, Inc. $596,192 Vaxart Inc $118,601 Tenax Therapeutics Inc $524,997 Cyclo Therapeutics, Inc $20,218,584 ReShape Lifesciences Inc $831,407 Avalo Therapeutics, Inc $14,783 Dynatronics Corp $233,800 Kiora Pharmaceuticals $625,814 Fresh Tracks Therapeutics Ord Shs $1,466,920 Alimera Sciences Inc $2,115,480 Cassava Sciences Inc $36,379,020 Bio-Path Holdings, Inc. $46,806 AYTU BIOSCIENCE, INC $4,228,491 Achieve Life Sciences Inc $4,404,511 AMAG Pharmaceuticals Inc $56,650,000 Onconova Therapeutics, Inc. $596,192 Vaxart Inc $118,601 Tenax Therapeutics Inc $524,997 Cyclo Therapeutics, Inc $20,218,584 ReShape Lifesciences Inc $831,407
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    99   
    96    

     Stock price went up :
    54   
    46    
     Stock price went down :
    45   
    50    
   
     Gain/Loss Ratio :
   1.2   
   1.2   
     Percentage Gain/Loss :
   -16.7%
 8,928.6%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Avalo Therapeutics, Inc AVTX 10% Owner 2023-06-27 34,370 2023-06-27 731,458    Premium*  
            Dynatronics Corp DYNT 10% Owner 2017-03-21 500,000 2017-03-21 1,000,000    Premium*  
            Kiora Pharmaceuticals KPRX 10% Owner 2021-01-06 3,346,601 2021-08-02 785,000    Premium*  
            Fresh Tracks Therapeutics Ord Shs FRTX 10% Owner 2019-01-10 2,170,000 2019-01-10 2,170,000    Premium*  
            Alimera Sciences Inc ALIM 10% Owner 2018-02-06 6,936,000 2018-02-06 6,936,000    Premium*  
            Cassava Sciences Inc SAVA 10% Owner 2018-10-03 1,651,340 2018-10-03 0    Premium*  
            Del Friscos Restaurant Group, Llc DFRG 10% Owner 2019-09-25 0 2019-09-25 0    Premium*  
            Valeritas Holdings Inc VLRX 10% Owner 2019-12-20 0 2019-12-20 0    Premium*  
            Bio-Path Holdings, Inc. BPTH 10% Owner 2019-01-18 129,298 2019-01-18 129,298    Premium*  
            AYTU BIOSCIENCE, INC AYTU Director 2021-03-29 1,342,378 2021-03-29 1,342,378    Premium*  
            Achieve Life Sciences Inc ACHV 10% Owner 2019-06-11 843,776 2019-06-11 843,776    Premium*  
            AMAG Pharmaceuticals Inc AMAG 10% Owner 2020-03-16 4,120,000 2020-03-16 348,000    Premium*  
            Onconova Therapeutics, Inc. ONTX 10% Owner 2019-09-23 816,702 2019-09-23 816,702    Premium*  
            Vaxart Inc VXRT Director 2020-06-29 145,523 2020-06-29 145,523    Premium*  
            Tetraphase Pharmaceuticals Inc TTPH Director, 10% Owner 2020-07-28 0 2020-07-28 0    Premium*  
            Tenax Therapeutics Inc TENX Director, 10% Owner 2020-09-08 2,019,995 2020-09-08 2,019,995    Premium*  
            Cyclo Therapeutics, Inc CYTH 10% Owner 2020-09-30 15,795,769 2020-09-30 15,795,769    Premium*  
            ReShape Lifesciences Inc RSLS 10% Owner 2021-06-28 7,223,346 2021-06-28 7,223,346    Premium*  
* Premium Members only  

Records found :    790         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 28 of 32
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-10-26 4 B $3.92 $220,195 D/D 55,899 17,730,308 3.92 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-10-29 4 B $3.94 $131,047 D/D 33,292 17,763,600 3.92 -
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2018-10-24 4 B $3.95 $340,410 D/D 83,800 17,655,800 2.45 -
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2023-02-03 4 A $3.95 $1,319 I/I 334 3,965,000 0 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-10-30 4 B $3.97 $5,559 D/D 1,400 17,765,000 3.84 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2020-02-03 4 B $3.98 $3,905,502 D/D 981,282 29,664,515 3.92 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-10-25 4 B $3.99 $74,270 D/D 18,609 17,674,409 3.92 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-06-28 4 B $4.03 $58,482 D/D 14,400 16,414,400 3.92 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-04-23 4 B $4.17 $25,795 D/D 6,189 16,220,000 3.92 -
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2018-10-23 4 B $4.20 $92,365 D/D 22,000 17,572,000 2.45 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-07-31 4 B $4.21 $2,757 D/D 655 16,480,000 3.84 -
VLRX Valeritas Holdings Inc 10% Owner   –       –       •   2019-05-20 4 B $4.24 $42,400 D/D 10,000 1,020,000 2.37 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-07-16 4 B $4.25 $75,765 D/D 17,800 16,436,000 3.92 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-07-30 4 B $4.26 $9,377 D/D 2,200 16,479,345 3.84 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-07-02 4 B $4.28 $16,276 D/D 3,800 16,418,200 3.92 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-07-17 4 B $4.30 $41,774 D/D 9,719 16,445,719 3.92 -
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2018-10-22 4 B $4.31 $86,290 D/D 20,000 17,550,000 2.45 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-10-05 4 B $4.32 $6,471 D/D 1,497 17,503,912 3.84 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-10-08 4 B $4.33 $84,785 D/D 19,588 17,523,500 3.92 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-07-25 4 B $4.34 $33,404 D/D 7,700 16,455,919 3.92 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-07-18 4 B $4.35 $10,866 D/D 2,500 16,448,219 3.92 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-10-04 4 B $4.35 $8,755 D/D 2,015 17,502,415 3.84 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-10-09 4 B $4.35 $28,393 D/D 6,500 17,530,000 3.92 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-07-27 4 B $4.41 $75,871 D/D 17,145 16,477,145 3.92 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-07-26 4 B $4.48 $18,301 D/D 4,081 16,460,000 3.92 -
  790  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28  29   30   31   32      
  Page 28 of 32  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us